Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Operating Margin for Spero Therapeutics (SPRO)
Operating Margin as of May 2024 (TTM): -92.06%
According to Spero Therapeutics's latest financial reports and stock price the company's current Operating Margin is -92.06%. At the end of 2021 the company had an Operating Margin of -491.65%.
Operating Margin history for Spero Therapeutics from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -491.65% | -98.38% |
| 2020 | -30,341.09% | 2261.55% |
| 2019 | -1,284.80% | |
| 2016 | -9,743.58% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 IBM IBM | 3.08% | -103.35% | 🇺🇸 USA |
 Thomson Reuters
TRI | 29.92% | -132.50% | 🇨🇦 Canada |
 Franklin Covey FC | 8.21% | -108.92% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.